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Object. Neuroimaging-guided stereotactic biopsy procedures are commonly used for diagnosis of gliomas. A number of the imaging modalities currently in use are not reliable enough in depicting these tumors. The authors developed 18 Fcholine and 11 C-choline as tumor imaging agents for positron emission tomography (PET) scanning, and used them to visualize gliomas prior to stereotactic biopsy procedures.
Methods. The PET studies were performed in 12 patients who were thought to be affected by gliomas observed on computerized tomography and magnetic resonance images. The C-choline in the brain. The tumor uptake was constant between 5 and 20 minutes with both agents. Stereotactic biopsy sampling was performed to obtain tissues from the most radioactive areas on the PET scan; histological diagnoses were made using these tissues. The results were as follows: oligodendroglioma was found in two patients, astrocytoma in one, anaplastic astrocytoma in two, and glioblastoma in seven.
Conclusions. The uptake of contrast agents was always low in low-grade gliomas, and the uptake in high-grade glioma was always high. The tumor/normal (T/N) ratio of C-choline contrast agents were added would guide the approach to the most malignant areas for stereotactic biopsy sampling. The   18   F-choline  6 and   11 C-choline 9 contrast agents were prepared using the previously reported methods. The PET camera (Headtome IV, 6-mm spatial resolution; Shimadzu, Kyoto, Japan) was used for data acquisition. The PET scans were produced as follows: first a transmission scan was performed, then 18 F-or 11 C-choline (370 MBq each) was injected intravenously. At 5 and 20 minutes postinjection, the first and second emission scans were started; the data acquisition time was 3 minutes each. Finally, the computer displayed the radioactivity distribution image on the scale of the standardized uptake value in color, where this value was calculated as follows: (regional radioactivity concentration)/(total injected dose/body weight). One pixel corresponded to a tissue volume of 4 ϫ 4 ϫ 9.5 mm. The computer showed alternatively a numerical value of the standardized uptake value within a selected region of interest.
Positron Emission Tomography Scanning Procedure

Quantification of PET Data
The area of highest uptake in the brain was enclosed within a region of interest of approximately 12 pixels, and its standardized uptake value was calculated (to equal tumor uptake). Normal gray matter of the contralateral posterior temporal lobe was used as a reference, and its standardized uptake value was calculated (to equal normal uptake). The T/N ratio was defined as the ratio of tumor uptake to normal tissue uptake of contrast material. The radioactivities in normal gray and white matter were very low. Low-grade glioma was visualized as a slightly positive area, whereas glioblastoma was visualized as a highly positive area. The bone marrow of the cranium was visualized. Figure 2 shows the histological findings in these tumors (low-grade glioma and glioblastoma), whereas Fig. 3 shows the CT/MR imaging findings. The areas that enhanced with 18 F-and 11 C-choline on PET scans corresponded to the contrast-enhanced areas on CT (Fig. 3B ) and MR images (Fig. 3D) . C-choline, tumor uptake was low in low-grade glioma (Grade II oligodendroglioma and Grade II astrocytoma), and high in high-grade glioma (Grade III anaplastic astrocytoma and Grade IV glioblastoma). Tumor uptake was almost constant between 5 and 20 minutes with both tracers, whereas normal tissue uptake was very low, resulting in a very high T/N ratio. The Table 2 shows the particulars of tumor contour seen on CT, MR, and PET studies with addition of 18 F-and 11 Ccholine in all patients. Glioma was well delineated on PET scans, and the tumor size on PET studies was almost the same as that seen on contrast-enhanced CT and MR images (when the tumor enhanced). There were a few exceptions: PET scans were positive in nonenhanced areas in the patients in Cases 2 and 5, and PET scans were negative in an enhanced area in the patient in Case 8.
Results
Typical PET Scans, Histological Characteristics, and CT/MR Images of Low-Grade Glioma and Glioblastoma
Uptake of 18 F-and 11 C-Choline in Relation to the Histological Type of Glioma
Tumor Contour Revealed by CT, MR, and PET Studies
In one patient with oligodendroglioma (Case 1) no contrast enhancement was demonstrated on CT and MR images, and this corresponded to the absence of the uptake of The PET studies were always negative in the amorphous edematous area surrounding the tumor.
Discussion
It is our understanding that the definite diagnosis of glioma should be made only after biopsy sampling and histological examination. When a stereotactic biopsy procedure is intended, 18 F-and 11 C-choline PET scanning seems to be very helpful in determining the most malignant areas of gliomas, in which various grades of malignant tissues may be present heterogeneously.
Another application of 18 F-and 11 C-choline PET scanning would be for the differential diagnosis of previously treated gliomas to distinguish among tumor recurrence, inflammation, necrosis, and scar formation. In this case, both CT and MR images are poorly informative, because the information in contrast-enhanced CT and MR images may be seriously compromised by the reactive inflammatory changes. After surgery, the enhancement occurs in a few days at the site of treatment, and it may persist for several months. The enhancement may occur after a delay of several months following radiation therapy and it may be located adjacent to necrotic tissues or remotely as a consequence of radiationinduced telangiectasia. 12 Previously, when we introduced 11 C-choline for brain tumor imaging with PET, we found that untreated and recurrent high-grade gliomas were always visualized clearly with sharp delineation, and were devoid of the influence of reactive inflammatory changes. 6 We have now introduced 18 F-choline, and it is an improvement on the images obtained with line, 7 and theirs was [ Positron emission tomography with 11 C-methionine has also been widely used for imaging gliomas. Nevertheless, it has been reported that the T/N ratio of 11 C-methionine in glioblastoma was 2.36 Ϯ 0.73 (32 cases), 16 2.81 Ϯ 0.61 (15 cases), 11 or 2.79 Ϯ 0.7 (six cases), 19 where the tumor tissue uptake in standardized uptake value was 3.51 Ϯ 1.11 (32 cases), 16 and the normal tissue uptake in standardized uptake value was 1.51 Ϯ 0.37 (32 cases). 16 There are reports on the application of 
